Royal care Super Speciality Hospitals
As of April 24, 2025, Royal care Super Speciality Hospitals share price is INR 0.00 per share and the face value is INR 10.00 per share. The lot size of Royal care Super Speciality Hospitals is 0 shares. The 52 week high for Royal care Super Speciality Hospitals is INR 0.00, while the 52 week low is INR 0.00
About Royal care Super Speciality Hospitals
A Comprehensive Overview of Price & Journey
Understanding Royal care Super Speciality Hospitals Inception and Growth
SHOW MORE...About Royal care Super Speciality Hospitals
IPO Details, Price movement
Performance Highlights for FY 2023-24
-
The revenue from operations for the hospital was Rs. 332.73 Crores compared to the previous year, which stood at Rs. 305.48 Crores, an increase of 8.9%.
-
The revenue from operations is generated by four components, and these are inpatient revenue, Outpatients Revenue, Pharmacy Sales and Dietary.
-
The Revenue generated by these four in FY24 is Rs. 246.39 Crores, 50.26 Crores, 29.01 Crores and 7.05 Crores, respectively.
-
The profit before tax increased by 56.2% from 15.56 Crores in FY23 to Rs. 24.3 Crores in FY24.
-
The Profit After Tax for the year is Rs. 24.48 Crores
-
Earning Per Share (EPS) for FY24 is Rs. 1.43.
-
Total Assets for the Hospital Stood to Rs. 545.26 Crores.
-
There is a cash inflow of Rs. 87.18 Crores from operating activities and Rs. 25.29 Crores from financing activities.
-
The company spent cash of Rs. 90.26 Crores on investing activities.
-
This hospital is good to invest in for the investors as it generates good profits and looks financially healthy.
Fundamentals
Financials
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | - | 301.15 | 305.49 | 332.73 |
| Other Income | - | 4.22 | 5.16 | 5.19 |
| COGS | - | 71.23 | 68.57 | 72.76 |
| Gross Profit | - | 234.15 | 242.08 | 265.17 |
| Total Expense | - | 161.93 | 175.29 | 194.17 |
| EBIDTA | - | 72.22 | 66.79 | 71.00 |
| D&A | - | 23.72 | 24.39 | 24.53 |
| EBIT | - | 48.50 | 42.40 | 46.47 |
| Interest Expense | - | 27.17 | 26.84 | 22.15 |
| PBT | - | 21.32 | 15.56 | 24.32 |
| TAX | - | 0.09 | -0.11 | -0.17 |
| PAT | - | 21.23 | 15.68 | 24.48 |
| Diluted EPS | - | 1.29 | 0.95 | 1.43 |
| Basic EPS | - | 1.29 | 0.95 | 1.43 |
| Total income | 0.00 | 305.37 | 310.65 | 337.92 |
ASSETS
| CURRENT ASSETS | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Cash and Cash Equivalents | - | 8.31 | 5.04 | 27.25 |
| Trade Payables | - | 9.12 | 16.86 | 23.44 |
| Inventory | - | 6.51 | 9.01 | 13.31 |
| Other Current Assets | - | 14.40 | 14.25 | 9.51 |
| Total Current Assets | 0.00 | 38.34 | 45.16 | 73.51 |
| NON CURRENT ASSETS | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Plant Property and Equipment | - | 341.25 | 343.69 | 411.15 |
| Long Term Investment | - | 1.17 | 1.16 | 1.16 |
| Other Non Current Assets | - | 24.87 | 30.64 | 59.45 |
| TOTOAL NON CURRENT ASSSETS | 0.00 | 367.29 | 375.49 | 471.76 |
| Total Assets | 0.00 | 405.63 | 420.65 | 545.27 |
|---|
| CURRENT LIABILITES | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| TRADW Payable | - | 6.16 | 12.47 | 29.99 |
| Other Current Liab | - | 62.92 | 60.43 | 67.48 |
| Total Current Liab | 0.00 | 69.08 | 72.90 | 97.47 |
| NON CURRENTLIABILITIES | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Long Term Debt | - | 212.50 | 203.46 | 244.58 |
| Deffered Tax Liab | - | - | - | - |
| Other Non Current Liab | - | 6.01 | 10.60 | 8.50 |
LIABILITIES
| EQUITY | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Share Capital | - | 164.38 | 164.38 | 171.02 |
| Reserves And Surplus | - | - | - | - |
| Other Equity | - | -46.34 | -30.67 | 23.70 |
| Retained Earnings | - | - | - | - |
| share Equity | 0.00 | 118.04 | 133.71 | 194.72 |
| Total Liabilities | 0.00 | 336.55 | 347.77 | 447.80 |
|---|
| CASH FLOW STAT | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Cash Flow from operating | - | 83.40 | 58.96 | 87.18 |
| Cash Flow from financing | - | -35.18 | -36.33 | 25.29 |
| Cash Flow from investing | - | -43.22 | -25.90 | -90.27 |
| Net cash flow | 0.00 | 5.00 | -3.27 | 22.20 |
Revenue Growth
PAT Growth %
EPS Growth %
TOTAL ASSETS Growth %
QUICK RATIO Growth %
LONG TERM DEBT TO EQUITY RATIO Growth %
Frequently Asked Questions
- Please find below the procedure for buying Royal care Super Speciality Hospitals/Pre-IPO shares at Bharat Invest.
- You confirm booking of Royal care Super Speciality Hospitals/Pre-IPO shares with us at a specified price.
- You have to provide your client master report along with PAN Card and Cancelled Cheque in case you are not transferring funds from the bank account as mentioned in the CMR Copy. These are KYC documents required as per SEBI regulations.
- We will provide our bank details.
- You need to transfer funds in the current account of bharat invest.
- No cash deposit is accepted
- Payment has to be done from the same account in which shares are to be credited.
- We ensure delivery of Royal care Super Speciality Hospitals within 24 hours.
- Incase of non-availability of shares, we refund the amount to the same bank account within 24 hours.
- For detailed discussion, you can contact us via any medium.